Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ribas A et al. – The combination of MART–1 peptide–pulsed DC and tremelimumab results in objective and durable tumor responses at the higher range of the expected response rate with either agent alone.


Today in Derm Allergy/Immunology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Solar urticaria
Allergy and Asthma Proceedings, 10/12/09

The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations
Allergy, 11/16/09

Today in Vaccine/Immunotherapy...keeping you current

Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09

Effectiveness of Varicella Vaccines as Postexposure Prophylaxis
The Pediatric Infectious Disease Journal, 10/27/09

Safety of vaccination of patients with systemic lupus erythematosus
Lupus, 11/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address